Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Background: The prevalence, characteristics and implications of excessive arousal-activation in children and adolescents treated with antidepressants for specific illnesses have not been systematically examined. Methods: We compared reports of antidepressant trials (n = 6,767 subjects) in juvenile depressive (n = 17) and anxiety disorders (n = 25) for consensus-based indications of psychopathological mood elevation or behavioral activation. Results: Rates of excessive arousal-activation during treatment with antidepressants were at least as high in juvenile anxiety (13.8%) as depressive (9.79%) disorders, and much lower with placebos (5.22 vs. 1.10%, respectively; both p < 0.0001). The antidepressant/placebo risk ratio for such reactions in paired comparisons was 3.50 (12.9/3.69%), and the meta-analytically pooled rate ratio was 1.7 (95% confidence interval: 1.2-2.2; both p ≤ 0.001). Overall rates for ‘mania or hypomania', specifically, were 8.19% with and 0.17% without antidepressant treatment, with large drug/placebo risk ratios among depressive (10.4/0.45%) and anxiety (1.98/0.00%) disorder patients. Conclusions: Risks of excessive mood elevation during antidepressant treatment, including mania-hypomania, were much greater than with placebo, and similar in juvenile anxiety and depressive disorders. Excessive arousal-activation in children or adolescents treated with antidepressants for anxiety as well as depressive disorders calls for particular caution and monitoring for potential risk of future bipolar disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and meta-analysis explored hypomania, mania, and behavioral activation of children and adolescents during AD treatment.37 It disclosed that rates of excessive arousal-activation with antidepressants were very significantly higher both in anxiety (13.8%) and depression (9.8%), than with placebos (5.2 versus 1.1%, respectively).”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [37]
In the citing paper
“If it is an adap-DOI: 10.1159/000500151 tive response that mediates therapeutic actions at 2-4 weeks [49], it is also conceivable that further adaptive changes may occur at some later point in time.Such adaptive changes may take place through 5-HT1A autoreceptor activity [41], and/or be associated with the allosteric modulation of the serotonin transporter protein, which was recently detected with”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [50]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 985
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., et al. (2008) · JAMA · doi:10.1001/jama.299.8.901 · Cited by 700
Research works printed but not linked: 1
- 10.1176%2Fappi.ajp.164.2.290 · DOI
Cited by
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Self-citationBaldessarini, R. J., Faedda, G. L., Offidani, E., Vázquez, G. H., Marangoni, C., Serra, G., & Tondo, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.033 · Cited by 169
Self-citationOffidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Self-citationMarangoni, C., Hernandez, M., & Faedda, G. L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.055 · Cited by 158
Annual Research Review: Defining and treating pediatric treatment‐resistant depression
Dwyer, J. B., Stringaris, A., Brent, D. A., & Bloch, M. H. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13202 · Cited by 148
Antidepressants and Suicidality
Brent, D. A. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.04.002 · Cited by 119
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123
Rucklidge, J. J., Frampton, C. M., Gorman, B., & Boggis, A. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.132126 · Cited by 141
Comorbidity in pediatric bipolar disorder: Prevalence, clinical impact, etiology and treatment
Frías, Á., Palma, C., & Farriols, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.008 · Cited by 125
Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management
Luft, M. J., Lamy, M., DelBello, M. P., McNamara, R. K., & Strawn, J. R. (2018) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2017.12.001 · Cited by 106
“Specifically, a recent meta-analysis failed to find significant differences in the relative risk of “excessive mood elevation” observed in studies (κ 1⁄4 42) of patients with anxiety (κ 1⁄4 17) or depressive disorders (κ 1⁄4 25).(38) In this meta-analysis, the “mood elevation” symptoms included insomnia, restlessness,…”
BackgroundFava, G. A., Ruini, C., & Linden, M. (2016) · Wiley eBooks · doi:10.1002/9781118468197.ch26 · Cited by 103
Self-citationIngul, J. M., Aune, T., & Nordahl, H. M. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000354672 · Cited by 98
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Self-citationDepressive disorders in childhood and adolescence
Brent, D., & Maalouf, F. (2015) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781118381953.ch63 · Cited by 94
Vázquez, G. H., Baldessarini, R. J., & Tondo, L. (2014) · Depression and Anxiety · doi:10.1002/da.22248 · Cited by 93
Self-citationThe reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
“In addition, use of antidepressants in vulnerable patients, especially those who are young, may be associated with a switch to mania or hypomania [93].”
BackgroundMeta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
Radua, J., Grunze, H., & Amann, B. L. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000449417 · Cited by 86
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Self-citationIatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Self-citationMixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use
Sani, G., Napoletano, F., Vöhringer, P. A., Sullivan, M., Simonetti, A., Koukopoulos, A., Danese, E., Girardi, P., & Ghaemi, N. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000358808 · Cited by 80
Psychological therapy for anxiety in bipolar spectrum disorders: A systematic review
Stratford, H. J., Cooper, M. J., Di Simplicio, M., Blackwell, S. E., & Holmes, E. A. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.11.002 · Cited by 63
Barbuti, M., Pacchiarotti, I., Vieta, E., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S. N., Young, A. H., & Perugi, G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.035 · Cited by 63
Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
Spielmans, G. I., Spence-Sing, T., & Parry, P. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00018 · Cited by 60
“Managing Antidepressant-Induced Suicidality The term “activation” refers to a group of adverse events which include mania, irritability, insomnia, agitation, restlessness, or excessive excitability (87, 88).”
BackgroundBehavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55
“1%, respectively).(14) Furthermore, in almost half of pediatric patients who participate in antidepressant trials, such reactions occur in absence of family history of bipolar disorder.”
BackgroundSelf-citationPharmacological treatment of children and adolescents with depression
Vitiello, B., & Ordóñez, A. E. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1244530 · Cited by 51
Cervin, M., Mcguire, J. F., D’Souza, J. M., Nadai, A. S. D., Aspvall, K., Goodman, W. K., Andrén, P., Schneider, S. C., GELLER, D. A., Mataix‐Cols, D., et al. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13934 · Cited by 55
Clinical and Environmental Risk Factors for Bipolar Disorder: Review of Prospective Studies
Marangoni, C., Faedda, G. L., & Baldessarini, R. J. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000161 · Cited by 43
Self-citationSSRI-Induced Activation Syndrome in Children and Adolescents—What Is Next?
Amitai, M., Chen, A., Weizman, A., & Apter, A. S. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0034-9 · Cited by 44
McClure, D., Greenman, S. C., Koppolu, S. S., Varvara, M., Yaseen, Z. S., & GALYNKER, I. I. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000378 · Cited by 38
“Antidepressants in bipolar depression can only be used with extreme caution because of the significant risk of mania and cycle acceleration (Post et al., 2003; Koszewska and Rybakowski, 2009; Offidani et al., 2013; Baldessarini et al., 2013).”
BackgroundSpielmans, G. I., & Gerwig, K. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000356191 · Cited by 31
Cosci, F., & Chouinard, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00007-x · Cited by 41
Rockstroh, F., Edinger, A., Josi, J., Fischer-Waldschmidt, G., Brunner, R. M., Resch, F., & Kaess, M. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000531092 · Cited by 31
Fornaro, M., Anastasia, A., Monaco, F., Novello, S., Fusco, A., Iasevoli, F., Berardis, D. D., Veronese, N., Solmi, M., & de Bartolomeis, A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.085 · Cited by 27
Clinimetric Perspectives in Clinical Psychology and Psychiatry
Cosci, F. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000517028 · Cited by 30
Rucklidge, J. J., Blampied, N. M., Gorman, B., Gordon, H., & Sole, E. J. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2392 · Cited by 26
“…however, our observation that medication use is not associated with good long-term recovery is consistent with the growing body of evidence documenting the disappointing long-term outcomes of medications (Fava, 2002; Whitaker, 2004; Molina et al., 2009; Advokat, 2010; Offidani et al., 2013).”
ResultOffidani, E., Fava, G. A., & Sonino, N. (2014) · CNS Drugs · doi:10.1007/s40263-014-0184-0 · Cited by 23
“1 %, respectively) [20].”
BackgroundResultInfluentialSelf-citationNimarko, A. F., Fischer, A. S., Hagan, K. E., Gorelik, A. J., Lu, Y., Young, C. J., & Singh, M. K. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.07.890 · Cited by 25
Present and future of developmental neuropsychopharmacology
Arango, C. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.003 · Cited by 23
Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.
Sparks, J. A., & Duncan, B. L. (2013) · Europe PMC (PubMed Central) · Cited by 23
Hengartner, M. P., Passalacqua, S., Andreae, A., Heinsius, T., Hepp, U., Rössler, W., & von Wyl, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00079 · Cited by 20
“For instance, in patients with mood and anxiety disorders, antidepressants may trigger psychomotor agitation and mania (47, 48) or suicidal acts (49, 50).”
BackgroundPannu, A. S., & Goyal, R. K. (2024) · Current Drug Safety · doi:10.2174/0115748863301630240417071353 · Cited by 29
Thienemann, M., Park, M., Chan, A. L., & Frankovich, J. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.01.022 · Cited by 16
Wu, J., Li, N., Gu, J., Shen, Y., Qiu, L., & Zhu, L. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.007 · Cited by 13
What psychologists need to know about psychotropic medications
Tomba, E., Guidi, J., & Fava, G. A. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2154 · Cited by 11
Self-citationLeckman, J. F. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345543 · Cited by 12
Treatment of Comorbid Anxiety Disorders and Depression
Fava, G. A., & Tomba, E. (2014) · The Wiley Handbook of Anxiety Disorders · doi:10.1002/9781118775349.ch53 · Cited by 10
Self-citationTürkmen, C., Machunze, N., Lee, A. M., Bougelet, E., Ludin, N. M., de Cates, A. N., Vollstädt‐Klein, S., Bach, P., Kiefer, F., Andreas, J. B., et al. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.01.006 · Cited by 13
Nardi, A. E., & Quagliato, L. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524730 · Cited by 14
Drug Safety and Suicidality Risk of Chronic Pain Medications
Syed, O., Jancic, P., Fink, A. B., & Knežević, N. N. (2023) · Pharmaceuticals · doi:10.3390/ph16101497 · Cited by 11
García-Delgar, B., Morer, Á., Varela, E., Romero, S., Giral, M. G., Coffey, B. J., & Lázaro, L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000923 · Cited by 10
The Emerging Role of Clinical Pharmacopsychology
Cosci, F., Guidi, J., Tomba, E., & Fava, G. A. (2019) · Clinical Psychology in Europe · doi:10.32872/cpe.v1i2.32158 · Cited by 9
Self-citationA certificate in youth psychiatry: meeting the training needs of psychiatrists
Macmillan, I., Thompson, A. D., Kalucy, M., Pellen, D., Killackey, E. J., McGorry, P. D., & Scott, J. G. (2020) · Australasian Psychiatry · doi:10.1177/1039856220943015 · Cited by 9
Lohse, M. J., & Müller-Oerlinghausen, B. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_41 · Cited by 7
Skarphéðinsson, G., & Ivarsson, T. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0047-0 · Cited by 8
“Clinicians should also be aware of agitation (behavioral activation) in younger children and demotivation [42].”
BackgroundLohse, M. J., Seifert, J., & Bleich, S. (2021) · Springer eBooks · doi:10.1007/978-3-662-63825-5_39 · Cited by 11
Gøtzsche, P. C., & Lund, K. (2016) · Kritisk juss · doi:10.18261/issn.2387-4546-2016-02-03 · Cited by 7
Activation syndrome in children and adolescents treated with selective serotonin reuptake inhibitors
Velasco, D. M. P., & Ospina‐Pinillos, L. (2024) · Revista Colombiana de Psiquiatría (English ed ) · doi:10.1016/j.rcpeng.2022.03.004 · Cited by 7
Karakaya, S. E. K., Yektaş, Ç., & Tufan, A. E. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000447 · Cited by 4
Lohse, M. J. (2020) · Springer eBooks · doi:10.1007/978-3-662-62168-4_38 · Cited by 5
Lohse, M. J., & Müller-Oerlinghausen, B. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_41 · Cited by 4
Lohse, M. J., & Müller-Oerlinghausen, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_41 · Cited by 10
Antidepressants and Suicidality—Controversies and Possible Mechanisms
Witt-Doerring, J., & Mathew, S. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00027-5 · Cited by 3
Lohse, M. J., & Müller-Oerlinghausen, B. (2015) · Springer eBooks · doi:10.1007/978-3-662-47186-9_38 · Cited by 5
O’Donnell, C., Demler, T. L., & Trigoboff, E. (2022) · PubMed · Cited by 5
Research Status in Clinical Practice Regarding Pediatric and Adolescent Bipolar Disorders
Liu, L., Meng, M., Zhu, X., & Zhu, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.882616 · Cited by 4
Bipolar (Manic-Depressive) Disorder
Tondo, L., & Baldessarini, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27008-6 · Cited by 3
Self-citationMood Disturbance in ADHD Due to a General Medical Condition
Ryder, J. G., & Silva, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64251-2_3 · Cited by 3
What's next for developmental psychiatry?
Leckman, J. F. (2013) · World Psychiatry · doi:10.1002/wps.20029 · Cited by 2
Misdiagnosis and a Suicide Attempt: The Importance of Accurate Evaluation and Treatment
Qureshi, N., Schofield, M., Maneta, E., & Coffey, B. J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.2472 · Cited by 3
Yektaş, Ç., & Tufan, A. E. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1407564 · Cited by 2
“%) compared with selective serotonin reuptake inhibitors (SSRIs) (3.7”
BackgroundInfluentialAntidepressants and Activation Syndrome: Decades Without Definition
Mills, J. (2021) · Issues in Mental Health Nursing · doi:10.1080/01612840.2021.1972662 · Cited by 1
“…emphasize differentiation of activation syndrome from treatment-emergent mania, and some sources emphasize the overlap (Gökçen et al., 2019; Murphy et al., 2008; Offidani et al., 2013; Reid et al., 2010; Sinclair et al., 2009; Strawn et al., 2017; Takeshima & Oka 2013; Tanaka et al., 2007).”
BackgroundBrent, D. A., & Birmaher, B. B. (2013) · Evidence-Based Mental Health · doi:10.1136/eb-2013-101492 · Cited by 1
Gagnreynd meðferð við áráttu- og þráhyggjuröskun hjá börnum og unglingum: Yfirlitsgrein
Skarphéðinsson, G., Lauth, B., Njarðvík, U., & Ivarsson, T. (2016) · Læknablaðið · doi:10.17992/lbl.2016.04.75 · Cited by 3
Lacasse, J. R., Dunleavy, D. J., & Hughes, S. (2021) · Child and Adolescent Social Work Journal · doi:10.1007/s10560-020-00731-y · Cited by 3
Psychopharmacology for Pediatric OCD and Related Disorders
Greenberg, E., Johnson, G., & GELLER, D. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_10 · Cited by 1
Hulvershorn, L. A., & Leibenluft, E. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch52 · Cited by 1
Kravitz, R. E. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.136507
Child/Adolescent Anxiety Multimodal Study Safety
Sallee, F. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.12.009 · Cited by 1
Whitaker, R. B., & Cosgrove, L. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137516022_9
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00015-5
Self-citationManía e hipomanía inducida por antidepresivos en niños y adolescentes. Revisión bibliográfica
León, E. A. (2021) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v32i152.44 · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2013) · Springer eBooks · doi:10.1007/978-3-642-37124-0_39 · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_41 · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-43487-1_39 · Cited by 3
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00014-3
Self-citationVelasco, D. M. P., & Ospina‐Pinillos, L. (2022) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2022.03.005 · Cited by 1
Shum, W. G. (2022) · AIP conference proceedings · doi:10.1063/5.0094817
Latent bipolar depression – Authors' reply
Eyre, O., Patel, V., Brent, D. A., & Thapar, A. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02598-3
Case report - Sertraline induced psychosis
Cristal Clinique, B., Dumitrescu, M. R., Morasan, A. E., & CETTT “Sf. Stelian”, B. (2017) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2017.4.6
Gehrke, J. M., & Becker, F. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-261
Prescribing in Children and Adolescents
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg005.pub2
Les manifestations cliniques associées à la toxicité comportementale
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00003-0
Self-citationPrévention de la dépendance et de la symptomatologie du sevrage dus aux traitements antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00012-1
Self-citationGökçen, O., Karataş, K. S., Akkuş, M., Dönmez, F., & Konak, M. A. (2026) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001871
Metadata
- Authors
- Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J.
- Affiliations
- University of Bologna (IT)
- University at Buffalo, State University of New York (US)
- Harvard University (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 82
- Issue
- 3
- Pages
- 132-141
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2012863293
- Cited by
- 94
- References
- 101
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 16 · 2013: 7
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- antidepressant side effects, behavioral activation, mania, hypomania, adolescent depression, children and adolescents, bipolar disorder risk, placebo comparison, antidepressant trials
- MeSH terms
- Adolescent, Affect, Age Factors, Antidepressive Agents, Anxiety Disorders, Arousal, Bipolar Disorder, Child, Depressive Disorder, Emotions, Humans, Placebos, Risk Factors, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.